Immunoadsorption in the treatment of Acquired Haemophilia
Authors:
- Heike ZeitlerHZHeike Zeitler
- Gudrun Ulrich-MerzenichGUGudrun Ulrich-Merzenich
- Darius PanekDPDarius Panek
- Georg GoldmannGGGeorg Goldmann
- Natascha VidovicNVNatascha Vidovic
- Hans-Hermann BrackmannHBHans-Hermann Brackmann
- Johannes OldenburgJOJohannes Oldenburg
- 1 December 2009
- journal article
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 10 (5) , 122-125
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The relevance of the bleeding severity in the treatment of acquired haemophilia – an update of a single‐centre experience with 67 patientsHaemophilia, 2010
- Cautions and caveats to the treatment of acquired hemophilia AHaematologica, 2009
- International recommendations on the diagnosis and treatment of patients with acquired hemophilia AHaematologica, 2009
- Acquired factor VIII inhibitorsBlood, 2008
- Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisalHaemophilia, 2007
- Treatment of acquired hemophilia AJournal of Thrombosis and Haemostasis, 2007
- Treatment and outcome of acquired haemophilia A with a standard conventional regimen in a cohort without associated conditionsHaemophilia, 2006
- Treatment of acquired hemophilia by the Bonn-Malmö Protocol: documentation of an in vivo immunomodulating conceptBlood, 2005
- Acquired Haemophilia: Review and Meta‐Analysis Focused on Therapy and Prognostic FactorsBritish Journal of Haematology, 2003
- A Detailed Comparison of the Performance of the Standard versus the Nijmegen Modification of the Bethesda Assay in Detecting Factor VIII:C Inhibitors in the Haemophilia A Population of CanadaThrombosis and Haemostasis, 1998